Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer

BACKGROUND: Patients (pts) with metastatic rectal cancer and symptomatic primary, require local and systemic control. Chemotherapy used during chemoradiotherapy (CRT) is adequate for radiosensitisation, but suboptimal for systemic control. The aim of this phase II study was to assess tolerability, l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Autores principales: Michael, M, Chander, S, McKendrick, J, MacKay, J R, Steel, M, Hicks, R, Heriot, A, Leong, T, Cooray, P, Jefford, M, Zalcberg, J, Bressel, M, McClure, B, Ngan, S Y
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229632/
https://ncbi.nlm.nih.gov/pubmed/25211659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.487
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares